Paper40164682
Pim1 promotes the maintenance of bone homeostasis by regulating osteoclast function.
Seo J and 8 others. Exp Mol Med, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Pim1 promotes the maintenance of bone homeostasis by regulating osteoclast function. Papers, record 40164682. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40164682
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Proto-Oncogene Proteins c-pim-1 | Major topic |
| Osteoclasts | Major topic |
| Homeostasis | Major topic |
| Bone and Bones | Major topic |
| Animals | |
| Mice | |
| Signal Transduction | |
| Bone Resorption | |
| Mice, Knockout | |
| Mice, Inbred C57BL |
Source PubMed
References55
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38097734 | PIM1 drives lipid droplet accumulation to promote proliferation and survival in prostate cancer. | Oncogene | 2024 | https://conductscience.org/library/papers/38097734 | PubMed |
| 2 | 25642822 | The kinase MST4 limits inflammatory responses through direct phosphorylation of the adaptor TRAF6. | Nat Immunol | 2015 | https://conductscience.org/library/papers/25642822 | PubMed |
| 3 | 29563609 | RSK2 is required for TRAF6 phosphorylation-mediated colon inflammation. | Oncogene | 2018 | https://conductscience.org/library/papers/29563609 | PubMed |
| 4 | 28712664 | GSK3 and its interactions with the PI3K/AKT/mTOR signalling network. | Adv Biol Regul | 2017 | https://conductscience.org/library/papers/28712664 | PubMed |
| 5 | 16774853 | Coordination of microtubules and the actin cytoskeleton is important in osteoclast function, but calcitonin disrupts sealing zones without affecting microtubule networks. | Bone | 2006 | https://conductscience.org/library/papers/16774853 | PubMed |
| 6 | 20936937 | Disorders of bone remodeling. | Annu Rev Pathol | 2011 | https://conductscience.org/library/papers/20936937 | PubMed |
| 7 | 18426800 | The PIM1 kinase is a critical component of a survival pathway activated by docetaxel and promotes survival of docetaxel-treated prostate cancer cells. | J Biol Chem | 2008 | https://conductscience.org/library/papers/18426800 | PubMed |
| 8 | 26893828 | Pim-1 kinase as cancer drug target: An update. | Biomed Rep | 2016 | https://conductscience.org/library/papers/26893828 | PubMed |
| 9 | 24677373 | Molecular mechanisms of bone metastasis and associated muscle weakness. | Clin Cancer Res | 2014 | https://conductscience.org/library/papers/24677373 | PubMed |
| 10 | 15694833 | The serine/threonine kinase Pim-1. | Int J Biochem Cell Biol | 2005 | https://conductscience.org/library/papers/15694833 | PubMed |
| 11 | 24714644 | Podosome organization drives osteoclast-mediated bone resorption. | Cell Adh Migr | 2014 | https://conductscience.org/library/papers/24714644 | PubMed |
| 12 | 15280015 | Pim-1 kinase promotes inactivation of the pro-apoptotic Bad protein by phosphorylating it on the Ser112 gatekeeper site. | FEBS Lett | 2004 | https://conductscience.org/library/papers/15280015 | PubMed |
| 13 | 9254647 | Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts. | J Exp Med | 1997 | https://conductscience.org/library/papers/9254647 | PubMed |
| 14 | 21664461 | Reactive oxygen species regulate M-CSF-induced monocyte/macrophage proliferation through SHP1 oxidation. | Cell Signal | 2011 | https://conductscience.org/library/papers/21664461 | PubMed |
| 15 | 15694870 | Osteoclast-derived activity in the coupling of bone formation to resorption. | Trends Mol Med | 2005 | https://conductscience.org/library/papers/15694870 | PubMed |
| 16 | 12748652 | Osteoclast differentiation and activation. | Nature | 2003 | https://conductscience.org/library/papers/12748652 | PubMed |
| 17 | 10968781 | Therapeutic approaches to bone diseases. | Science | 2000 | https://conductscience.org/library/papers/10968781 | PubMed |
| 18 | 18775204 | Bisphosphonates: mechanism of action and role in clinical practice. | Mayo Clin Proc | 2008 | https://conductscience.org/library/papers/18775204 | PubMed |
| 19 | 27651368 | Pim kinase isoforms: devils defending cancer cells from therapeutic and immune attacks. | Apoptosis | 2016 | https://conductscience.org/library/papers/27651368 | PubMed |
| 20 | 29047262 | Current Understanding of RANK Signaling in Osteoclast Differentiation and Maturation. | Mol Cells | 2017 | https://conductscience.org/library/papers/29047262 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41920144 | PIM1 Inhibition Alleviates Aspergillus fumigatus Keratitis by Regulating DDX41-Mediated STING Signaling Pathway. | Invest Ophthalmol Vis Sci | 2026 | https://conductscience.org/library/papers/41920144 | PubMed |
| 41208856 | Enhanced pharmacokinetic and therapeutic of GSH-responsive mPEG-b-P(HPMA)-SGI1776 conjugate for osteosarcoma. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41208856 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40164682
GET https://conductscience.org/api/papers/v1/40164682/references?page=2